Special Issue "Safety of Complementary Medicines"

A special issue of Medicines (ISSN 2305-6320).

Deadline for manuscript submissions: closed (30 November 2018)

Special Issue Editor

Guest Editor
Assoc. Prof. Dr. Chun Guang Li

National Institute of Complementary Medicine (NICM), Western Sydney University, Penrith, NSW 2751, Australia
Website | E-Mail

Special Issue Information

Dear Colleagues,

Complementary medicines (CM) include a diverse range of therapies and products, such as acupuncture, naturopathy, vitamin and mineral supplements, mind–body practices, etc. These therapies have long been used in many countries, and, in recent times, are increasingly used in communities for preventing or managing various diseases and conditions. Some CM therapies are based on traditional practice systems, such as traditional Chinese medicine and Ayurvedic medicine, others are related to the conventional medical practice as supportive therapies. The health benefit of CM is mainly supported by traditional evidence with limited scientific evidence available. On the other hand, there are frequent concerns on their quality and safety which are often associated with product quality, improper practice, contaminants and toxicities of certain ingredients in CM products, such as pesticide residues, heavy metal and microbial contaminants in herbal medicines. It is important to understand the safety aspects of CM in order to minimise the potential risks involved and improve the quality practice/use of CM therapies and products.

This Special Issue invites original contributions, including review articles and practice guidelines, on all aspects of complementary medicines, including basic and clinical research on CM practice and related products, such as surveys, herbal toxicity, drug–herb interactions, contaminants and detections, as well as relevant quality control standards.

Assoc. Prof. Dr. Chun Guang Li
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 350 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • Complementary medicines
  • Traditional Chinese medicine
  • Ayurvedic medicine
  • vitamin and mineral supplements
  • acupuncture
  • herbal toxicity
  • herbal-drug interaction
  • contaminant & adulation
  • adverse reactions

Published Papers (7 papers)

View options order results:
result details:
Displaying articles 1-7
Export citation of selected articles as:


Jump to: Review, Other

Open AccessArticle
PharmActa: Empowering Patients to Avoid Clinical Significant Drug–Herb Interactions
Received: 11 January 2019 / Revised: 15 February 2019 / Accepted: 15 February 2019 / Published: 16 February 2019
PDF Full-text (1441 KB) | HTML Full-textXML Full-text
Open AccessArticle
Guggulsterone Activates Adipocyte Beiging through Direct Effects on 3T3-L1 Adipocytes and Indirect Effects Mediated through RAW264.7 Macrophages
Received: 19 December 2018 / Revised: 18 January 2019 / Accepted: 27 January 2019 / Published: 31 January 2019
PDF Full-text (2485 KB) | HTML Full-textXML Full-text
Open AccessArticle
Pilot Studies on Two Complementary Bath Products for Atopic Dermatitis Children: Pine-Tar and Tea
Received: 26 September 2018 / Revised: 24 December 2018 / Accepted: 28 December 2018 / Published: 8 January 2019
PDF Full-text (535 KB) | HTML Full-textXML Full-text
Open AccessArticle
Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients
Medicines 2018, 5(3), 100; https://doi.org/10.3390/medicines5030100
Received: 20 August 2018 / Revised: 3 September 2018 / Accepted: 4 September 2018 / Published: 6 September 2018
Cited by 1PDF Full-text (1123 KB) | HTML Full-textXML Full-text


Jump to: Research, Other

Open AccessReview
Current Status and Major Challenges to the Safety and Efficacy Presented by Chinese Herbal Medicine
Received: 19 December 2018 / Revised: 12 January 2019 / Accepted: 15 January 2019 / Published: 18 January 2019
PDF Full-text (251 KB) | HTML Full-textXML Full-text
Open AccessReview
Medicinal Cannabis—Potential Drug Interactions
Received: 30 November 2018 / Revised: 19 December 2018 / Accepted: 21 December 2018 / Published: 23 December 2018
PDF Full-text (467 KB) | HTML Full-textXML Full-text


Jump to: Research, Review

Open AccessCase Report
Use of Acupuncture in an Infant with Restlessness and Agitation
Received: 5 May 2018 / Revised: 7 June 2018 / Accepted: 11 June 2018 / Published: 13 June 2018
PDF Full-text (577 KB) | HTML Full-textXML Full-text
Medicines EISSN 2305-6320 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top